Expect Fewer Inhaled Steroids to Be Used for COPD

More bronchodilators and fewer inhaled corticosteroids will be used for COPD...due to new guidelines.

Many COPD patients get an inhaled steroid/long-acting beta-agonist combo (Advair, Breo, Symbicort) for persistent symptoms.

But combining two long-acting bronchodilators prevents more exacerbations...and has a lower risk of pneumonia than steroid combos.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote